October 09, 2026 10:49 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes | ‘He was never wavering while expressing his opinions’: PM Modi mourns Nana Patekar | Nana Patekar dies at 75: Veteran actor suffers cardiac arrest at Goa home | RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50%
Covid-19
NDMC worker sanitises Indian Parliament (Image Credit: UNI)

India adds close to 98,000 Covid-19 cases in 24 hours, tally crosses 51-lakh mark

| @indiablooms | Sep 17, 2020, at 04:10 pm

New Delhi/IBNS: The total number of Novel Coronavirus cases in India on Thursday crossed the 51-lakh mark as the country of 1.3 billion people reported a record spike in Covid-19 cases by adding 97,894 fresh infections in the last 24 hours.

With the new cases, India's Covid-19 tally has touched 51,18,253.

83,198 Covid-19 patients have so far succumbed to the virus with 1,132 people dying from the disease in the last 24 hours.

Meanwhile, the Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, which has been developed by pharmaceutical giant AstraZeneca and Oxford University.

The Oxford vaccine trial was first halted by AstraZeneca after a suspected serious adverse reaction was seen in a participant in the United Kingdom last week.

Following the development, the SII had also halted the vaccine trials in the country.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.